Skip to main content

Table 2 Predictors of Viral Hepatitis

From: Seroprevalence of hepatitis B virus infection, anti-HCV antibodies and HIV and knowledge among people who use drugs attending methadone therapy clinic in Tanzania; a cross-sectional study

  HBsAg /anti-HCV positive
Crude Odd Ratio(95%CI) P value Adjusted Odds Ratio (95% CI) P value
Age > 35 2.3(0.6–8.8) 0.001 4.5(1.2–16.9) 0.02
Address
 Kirumba 4.3 (1.5–11.9) 0.006 5.1(1.7–15.3) 0.004
 Sahara 0.7(0.1–5.4) 0.70 α  
 Bugarika 2.5(0.5–11.9) 0.27 α  
 Igogo 1.1(0.1–9.4) 0.89 α  
Married (compared to single) 1.7(0.6–4.8) 0.29 α  
Low education level 10.4(0.1–2.8) 0.33 α  
Having multiple sexual partners 1.8(0.6–5.8) 0.32 α  
Using drugs> 9 years 3.8(1.2–12.0) 0.03 2.1(0.5–8.6) 0.29
Use of multiple drugs 1.2(0.3–5.0) 0.78 α  
Route of drug use, injection 3.5(1.1–10.9) 0.02 3.2(0.9–10.8) 0.06
  1. Key: CI Confidence interval
  2. α Not included in multivariate analysis